Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Senior Officer Guillermo Torre purchased 17,240 shares of the firm's stock in a transaction dated Thursday, December 26th. The shares were purchased at an average cost of C$1.81 per share, for a total transaction of C$31,277.77.
Cardiol Therapeutics Price Performance
Shares of Cardiol Therapeutics stock traded up C$0.01 on Thursday, hitting C$1.81. The company's stock had a trading volume of 10,756 shares, compared to its average volume of 134,137. The company has a quick ratio of 6.84, a current ratio of 2.39 and a debt-to-equity ratio of 1.07. The firm has a fifty day moving average price of C$2.31 and a 200-day moving average price of C$2.65. Cardiol Therapeutics Inc. has a 52-week low of C$1.09 and a 52-week high of C$4.26. The company has a market capitalization of C$126.48 million, a P/E ratio of -4.11 and a beta of 0.70.
Cardiol Therapeutics Company Profile
(
Get Free Report)
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
See Also
Before you consider Cardiol Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.
While Cardiol Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
